Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer

被引：0
|
作者：
O. Köstek
N. C. Demircan
A. Gökyer
A. Küçükarda
B. S. Sunal
M. B. Hacıoğlu
H. Eslame
S. Solak
E. Yılmaz
S. Uzunoğlu
N. Tunçbilek
İ. Çiçin
B. Erdoğan
机构：
[1] Trakya University School of Medicine,Division of Medical Oncology, Department of Internal Medicine
[2] Trakya University School of Medicine,Department of Radiology
[3] Trakya University School of Medicine,undefined
来源：
Clinical and Translational Oncology | 2019年 / 21卷
关键词：
Skeletal muscle mass; Anti-EGFR treatment; Metastatic colorectal cancer; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1510 / 1517
页数：7
相关论文
共 50 条
  • [1] Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer
    Kostek, O.
    Demircan, N. C.
    Gokyer, A.
    Kucukarda, A.
    Sunal, B. S.
    Hacioglu, M. B.
    Eslame, H.
    Solak, S.
    Yilmaz, E.
    Uzunoglu, S.
    Tuncbilek, N.
    Cicin, I.
    Erdogan, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (11): : 1510 - 1517
  • [2] Efficacy and safety of anti-EGFR monoclonal antibodies combined with different chemotherapy regimens in patients with RAS wild-type metastatic colorectal cancer: A meta-analysis
    Sun, Huan
    Li, Yonghong
    Su, Yana
    Wu, Xinyu
    Zhou, Xiaoqin
    Han, Jin
    Li, Jing
    JOURNAL OF EVIDENCE BASED MEDICINE, 2019, 12 (04) : 300 - 312
  • [3] Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
    Amitani, Masatsugu
    Oba, Takaaki
    Kiyosawa, Nami
    Morikawa, Hiroki
    Chino, Tatsunori
    Soma, Ai
    Shimizu, Tadafumi
    Ohno, Koichi
    Ono, Mayu
    Ito, Tokiko
    Kanai, Toshiharu
    Maeno, Kazuma
    Ito, Ken-ichi
    BMC CANCER, 2022, 22 (01)
  • [4] Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
    Masatsugu Amitani
    Takaaki Oba
    Nami Kiyosawa
    Hiroki Morikawa
    Tatsunori Chino
    Ai Soma
    Tadafumi Shimizu
    Koichi Ohno
    Mayu Ono
    Tokiko Ito
    Toshiharu Kanai
    Kazuma Maeno
    Ken-ichi Ito
    BMC Cancer, 22
  • [5] Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: A systematic review and metanalysis
    Belluomini, L.
    Carandina, I.
    Bonetti, F.
    Urbini, B.
    Daniel, F.
    Lancia, F.
    Martella, L. R.
    Toma, I.
    Moretti, A.
    Banno, E.
    Nisi, C.
    Da Ros, L.
    Frassoldati, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: a systematic review and metanalysis regular
    Carandina, I.
    Belluomini, L.
    Bonetti, F.
    Urbini, B.
    Daniel, F.
    Lancia, F.
    Martella, L. R.
    Toma, I.
    Moretti, A.
    Banno, E.
    Nisi, C.
    Da Ros, L.
    Frassoldati, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer
    Cardone, Claudia
    Blauensteiner, Bernadette
    Moreno-Viedma, Veronica
    Martini, Giulia
    Simeon, Vittorio
    Vitiello, Pietro P.
    Ciardiello, Davide
    Belli, Valentina
    Matrone, Nunzia
    Troiani, Teresa
    Morgillo, Floriana
    Marino, Federica Zito
    Dentice, Monica
    Nappi, Annarita
    Boccaccino, Alessandra
    Antoniotti, Carlotta
    Cremolini, Chiara
    Pietrantonio, Filippo
    Prager, Gerald W.
    Normanno, Nicola
    Maiello, Evaristo
    Argiles, Guillem
    Elez, Elena
    Signoriello, Giuseppe
    Franco, Renato
    Falcone, Alfredo
    Tabernero, Josep
    Sibilia, Maria
    Ciardiello, Fortunato
    Martinelli, Erika
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : 1 - 10
  • [8] Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment
    Thomsen, Caroline Brenner
    Andersen, Rikke Fredslund
    Lindebjerg, Jan
    Hansen, Torben Frostrup
    Jensen, Lars Henrik
    Jakobsen, Anders
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : 28 - +
  • [9] EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer
    Algars, Annika
    Sundstrom, Jari
    Lintunen, Minnamaija
    Jokilehto, Terhi
    Kytola, Soili
    Kaare, Milja
    Vainionpaa, Reetta
    Orpana, Arto
    Osterlund, Pia
    Ristimaki, Ari
    Carpen, Olli
    Ristamaki, Raija
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 922 - 929
  • [10] Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients
    Zlobec, Inti
    Molinari, Francesca
    Martin, Vittoria
    Mazzucchelli, Luca
    Saletti, Piercarlo
    Trezzi, Rosangela
    De Dosso, Sara
    Vlajnic, Tatjana
    Frattini, Milo
    Lugli, Alessandro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (38) : 4823 - 4831
12345